Ipsen Sa ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPSEY | UTHR | NBIX | ||
| Company | Ipsen Sa ADR | United Therapeutic | Neurocrine Bioscienc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 49.0850 | 569.00 | 131.79 | ||
| High | 49.0850 | 573.30 | 132.41 | ||
| Low | 49.0850 | 565.56 | 129.86 | ||
| Latest | 49.0850 | 570.40 | 131.78 | ||
| Change | -0.7150 | -0.95 | +0.11 | ||
| % Change | -1.44% | -0.17% | +0.08% | ||
| Volume | 2,400 | 186,100 | 680,000 | ||
| 20-Day Average Volume | 1,110 | 423,970 | 1,179,270 | ||
| Previous Close | 49.8000 | 571.35 | 131.67 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.8153 | 573.32 | 130.45 | ||
| 20-Day Raw Stochastic | 89.34% | 43.44% | 72.79% | ||
| 20-Day Relative Strength | 65.07 | 56.33 | 51.62 | ||
| Weighted Alpha | +71.45 | +77.72 | +11.43 | ||
| Today's Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.10% since 04/17/26 | +0.57% since 04/24/26 | +3.21% since 04/24/26 | ||
| Low | 47.9500 on 04/28/26 | 561.00 on 04/29/26 | 126.49 on 04/29/26 | ||
| High | 49.8000 on 04/29/26 | 579.58 on 04/30/26 | 134.11 on 04/30/26 | ||
| 1-Month | |||||
| %Chg | +11.54% since 03/30/26 | +0.02% since 04/01/26 | -0.59% since 04/01/26 | ||
| Low | 45.7600 on 03/31/26 | 551.30 on 04/02/26 | 125.31 on 04/06/26 | ||
| High | 49.8000 on 04/29/26 | 593.65 on 04/20/26 | 134.20 on 04/07/26 | ||
| 3-Month | |||||
| %Chg | +20.42% since 01/30/26 | +21.49% since 01/30/26 | -3.15% since 01/30/26 | ||
| Low | 39.6900 on 02/05/26 | 464.44 on 02/11/26 | 122.14 on 02/12/26 | ||
| High | 49.8000 on 04/29/26 | 607.89 on 03/30/26 | 142.82 on 02/10/26 | ||
| 6-Month | |||||
| %Chg | +38.58% since 10/30/25 | +28.06% since 10/31/25 | -7.98% since 10/31/25 | ||
| Low | 34.3400 on 01/05/26 | 430.02 on 11/04/25 | 122.14 on 02/12/26 | ||
| High | 49.8000 on 04/29/26 | 607.89 on 03/30/26 | 160.18 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,456,139 | 24,999,488 | 13,254,696 | ||
| Shares Outstanding, K | 335,258 | 43,828 | 100,582 | ||
| Annual Sales | 4,445,500,000 | 3,182,700,000 | 2,860,500,000 | ||
| Annual Net Income | 501,780,000 | 1,334,700,000 | 478,600,000 | ||
| Last Quarter Sales | N/A | 790,200,000 | 805,500,000 | ||
| Last Quarter Net Income | N/A | 364,300,000 | 153,700,000 | ||
| 60-Month Beta | 0.49 | 0.60 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 7.70 on 02/25/26 | 1.88 on 02/11/26 | ||
| Earnings Date | 02/12/26 | 05/06/26 | 05/05/26 | ||
| Most Recent Dividend | 0.259 on 06/09/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/09/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 28.56 | ||